Joe Jonas is on a quest to make cosmetic injectables unisex. The most famous Jonas brother has signed on as the face of Xeomin, an FDA-approved Botox alternative. (This might explain why the singer has been looking so good as of late.)

The treatment, first approved for cosmetic use in 2011, is a form of botulinum toxin — just like Botox. In fact, the two injectables work the same way: by blocking movement in the muscles that cause wrinkles in the face and forehead.

In 2020, Xeomin tapped Gwyneth Paltrow — doctors' least-favorite wellness guru — as its first spokespersom. The company's pivot to Jonas shows just how much the beauty landscape has changed.

Injectables have always been available to both men and women, but marketing (and demand) skews heavily towards the latter. In 2015, the American society for Aesthetic Plastic surgery found that women accounted for 90.6 percent of all nonsurgical cosmetic procedures, a category that includes Botox injections.

As customers begin to evolve past gender binaries, Xeomin is wise to cater to a mostly untapped market. In fact, Jonas himself said that he hopes to reduce the hush-hush nature of men getting cosmetic procedures by partnering with the company.

"It’s something people obviously do and maybe they shy away from talking about it,” he told WWD. “It’s everyone’s choice if they don’t want to speak on it and that’s totally fine, but I think it doesn’t need to be something that has to be a secret. I hope to encourage people to feel like it’s not a big deal for them, meaning they don’t need to be nervous about speaking about how they take care of their body."

Jonas' sentiments reflect a growing trend in the aesthetics world. During the pandemic, the "Zoom effect" led more men to seek out cosmetic treatments, including filler and anti-wrinkle injections.

Jacob Steiger, a plastic surgeon in Miami, told The New York Times that male patients now account for about 25 percent of clients, versus approximately 10 percent pre-pandemic.

So come one, come all — we're all getting Xeomin shots this summer!

What To Read Next

  • Image on Highsnobiety

    Paul Smith Meets adidas' Stan Smith

  • Image on Highsnobiety

    Ye's Bedazzled Flip Flops, NFL = National Fenty League, MFW's Tumbling Moments

  • Image on Highsnobiety

    This Slinky Dress Was Literally Sprayed Onto Bella Hadid's Body

  • Image on Highsnobiety

    Knee-High Socks Have Been Bella Hadid-Approved

  • Image on Highsnobiety

    Bella Hadid: From Tighty-Whities to Formal Wear

  • Image on Highsnobiety

    Can Bella Hadid Make Wearing Tighty-Whities in Public a Thing?

*If you submitted your e-mail address and placed an order, we may use your e-mail address to inform you regularly about similar products without prior explicit consent. You can object to the use of your e-mail address for this purpose at any time without incurring any costs other than the transmission costs according to the basic tariffs. Each newsletter contains an unsubscribe link. Alternatively, you can object to receiving the newsletter at any time by sending an e-mail to

Web Accessibility Statement

Titelmedia (Highsnobiety), is committed to facilitating and improving the accessibility and usability of its Website, Titelmedia strives to ensure that its Website services and content are accessible to persons with disabilities including users of screen reader technology. To accomplish this, Titelmedia has engaged UsableNet Inc, a leading web accessibility consultant to help test, remediate and maintain our Website in-line with the Web Content Accessibility Guidelines (WCAG), which also bring the Website into conformance with the Americans with Disabilities Act of 1990.


Please be aware that our efforts to maintain accessibility and usability are ongoing. While we strive to make the Website as accessible as possible some issues can be encountered by different assistive technology as the range of assistive technology is wide and varied.

Contact Us

If, at any time, you have specific questions or concerns about the accessibility of any particular webpage on this Website, please contact us at, +49 (0)30 235 908 500. If you do encounter an accessibility issue, please be sure to specify the web page and nature of the issue in your email and/or phone call, and we will make all reasonable efforts to make that page or the information contained therein accessible for you.